Skip to main content

Table 2 Patients’ subgroups based on WHO Classification 2016

From: Clinico-Hematological and cytogenetic spectrum of adult myelodysplastic syndrome: The first retrospective cross-sectional study in Iranian patients

Subgroups Number of patients Normal cytogenetics Abnormal cytogenetics
MDS-MLD 38 (36.89%) 22 16
MDS-SLD 28 (18.44%) 17 11
MDS-EB MDS- EB-1 15 (14.56%) 11 4
MDS-EB -2 11 (10.67%) 5 6
MDS with isolated del(5q) 4 (3.88%) 0 4
MDS-RS 3 (2.91%) 1 2
MDS-U 4 (3.88%) 3 1
  1. MDS-MLD MDS with multilineage dysplasia, MDS-SLD MDS with single lineage dysplasia, MDS-EB MDS with excess blasts, MDS-RS MDS with ring sideroblasts, MDS-U MDS unclassifiable